The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2026 | Key unmet needs in LR-MDS: achieving transfusion independence, promising agents & more
In this video, María Díez Campelo, MD, PhD, University of Salamanca, Salamanca, Spain, highlights unmet needs in lower-risk myelodysplastic syndromes (LR-MDS), emphasizing the importance of achieving transfusion independence and the value of early treatment to improve quality of life and survival. This interview took place at the 31st Congress of the European Hematology Association (EHA) in Stockholm, Sweden.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
